406 related articles for article (PubMed ID: 8712650)
1. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
Bundred NJ; Walls J; Ratcliffe WA
Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.
Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A
Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637
[TBL] [Abstract][Full Text] [Related]
3. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites.
Powell GJ; Southby J; Danks JA; Stillwell RG; Hayman JA; Henderson MA; Bennett RC; Martin TJ
Cancer Res; 1991 Jun; 51(11):3059-61. PubMed ID: 2032246
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
5. [PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia].
Scharla SH; Pecherstorfer M; Lempert UG; Minne HW; Sarrach M; Baumgartner G; Ziegler R
Med Klin (Munich); 1991 Apr; 86(4):186-9. PubMed ID: 2056982
[TBL] [Abstract][Full Text] [Related]
6. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
7. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer.
Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ
J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.
Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW
Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone related protein in breast cancers of widely varying prognosis.
Kissin MW; Henderson MA; Danks JA; Hayman JA; Bennett RC; Martin TJ
Eur J Surg Oncol; 1993 Apr; 19(2):134-42. PubMed ID: 8491317
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
[TBL] [Abstract][Full Text] [Related]
11. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
Bouizar Z; Spyratos F; De vernejoul MC
J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.
Henderson MA; Danks JA; Slavin JL; Byrnes GB; Choong PF; Spillane JB; Hopper JL; Martin TJ
Cancer Res; 2006 Feb; 66(4):2250-6. PubMed ID: 16489028
[TBL] [Abstract][Full Text] [Related]
14. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
15. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
16. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
17. [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
Loibl S; Königs A; Kaufmann M; Costa SD; Bischoff J
Zentralbl Gynakol; 2006 Dec; 128(6):330-5. PubMed ID: 17213971
[TBL] [Abstract][Full Text] [Related]
18. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
Mihai R; Stevens J; McKinney C; Ibrahim NB
Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.
Wysolmerski JJ; Dann PR; Zelazny E; Dunbar ME; Insogna KL; Guise TA; Perkins AS
J Bone Miner Res; 2002 Jul; 17(7):1164-70. PubMed ID: 12096830
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue.
Downey SE; Hoyland J; Freemont AJ; Knox F; Walls J; Bundred NJ
J Pathol; 1997 Oct; 183(2):212-7. PubMed ID: 9390035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
